Luke Duncklee is a seasoned finance professional currently serving as Chief of Staff to the CFO and Sr. Director of Finance at Nanobiotix since January 2024. In this role, Luke supports the CFO and the finance team in critical initiatives, scenario analysis, and business development opportunities, while also developing external disclosure strategies. Prior experience includes serving as Financial Planning & Analysis Lead at Servier Pharmaceuticals, where Luke led budgeting and forecasting efforts and supported M&A activities. Earlier roles encompass managerial responsibilities in financial systems and senior accounting at RSM US LLP, complemented by an educational background in Economics with a concentration in Financial Markets from Colby College.